BioNexus Gene Lab (BGLC) Change in Acquisitions & Divestments (2021 - 2024)
BioNexus Gene Lab's Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $574036.0 for Q4 2024.
- Quarterly results put Change in Acquisitions & Divestments at $574036.0 for Q4 2024, up 81178.53% from a year ago — trailing twelve months through Mar 2025 was $857433.0 (up 261.04% YoY), and the annual figure for FY2024 was $1.1 million, up 3987.73%.
- Change in Acquisitions & Divestments for Q4 2024 was $574036.0 at BioNexus Gene Lab, up from $197063.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $574036.0 in Q4 2024 to a low of -$708.0 in Q4 2023.
- The 3-year median for Change in Acquisitions & Divestments is $56594.0 (2023), against an average of $136856.1.
- Peak annual rise in Change in Acquisitions & Divestments hit 81178.53% in 2024, while the deepest fall reached 633.83% in 2024.
- Year by year, Change in Acquisitions & Divestments stood at -$22.0 in 2021, then tumbled by 3118.18% to -$708.0 in 2023, then soared by 81178.53% to $574036.0 in 2024.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $574036.0, $197063.0, and $86334.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.